Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

S-phase kinase-associated protein 2 expression interference inhibits breast cancer cell proliferation

Y J Sun1, X K Wang2, B J Li2

  • 1Department of Pathology, Tianjin Fifth Central Hospital, Tangguc, Tianjin, China Yajingsun189@126.com.

Genetics and Molecular Research : GMR
|September 9, 2015
PubMed

Insights

Elevated S-phase kinase-associated protein 2 (SKP2) levels are found in breast cancer. Inhibiting SKP2 gene expression with small interfering RNA (siRNA) effectively slows breast cancer cell growth, indicating SKP2 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • S-phase kinase-associated protein 2 (SKP2) is implicated in cell cycle regulation and cancer progression.
  • Understanding SKP2 expression patterns in breast cancer is crucial for identifying new therapeutic strategies.

Purpose of the Study:

  • To investigate SKP2 expression levels in breast cancer tissues compared to normal tissues.
  • To evaluate the impact of SKP2 inhibition on breast cancer cell proliferation using siRNA technology.

Main Methods:

  • Western blotting and RT-PCR were employed to quantify SKP2 expression in patient tissue samples.
  • SKP2-specific small interfering RNA (siRNA) was utilized to reduce SKP2 levels in the MDA-MB-231 breast cancer cell line.
  • The MTT assay was performed to assess the effect of SKP2 inhibition on cell proliferation.

Main Results:

  • SKP2 expression was significantly higher in breast cancer tissues than in normal breast tissues (P < 0.05).
  • SKP2-specific siRNA effectively downregulated SKP2 expression in MDA-MB-231 cells.
  • Inhibition of SKP2 led to a significant decrease in breast cancer cell proliferation.

Conclusions:

  • Elevated SKP2 levels are a characteristic feature of breast cancer.
  • Targeting SKP2 through gene silencing inhibits breast cancer cell growth.
  • SKP2 represents a promising novel therapeutic target for breast cancer treatment.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K